Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors
============================================================================================================================================================

* Rachel E Sanborn
* Michael J Pishvaian
* Margaret K Callahan
* Amy Weise
* Branimir I Sikic
* Osama Rahma
* Daniel C Cho
* Naiyer A Rizvi
* Mario Sznol
* Jose Lutzky
* Julie E Bauman
* Rhonda L Bitting
* Alexander Starodub
* Antonio Jimeno
* David A Reardon
* Thomas Kaley
* Fabio Iwamoto
* Joachim M Baehring
* Deepa S Subramaniam
* Jeanny B Aragon-Ching
* Thomas R Hawthorne
* Tracey Rawls
* Michael Yellin
* Tibor Keler